Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 20,994 | 27,550 | 32,911 | 14,644 | 1,663 |
| Gross Profit | 20,994 | 27,550 | 32,911 | 14,644 | 1,663 |
| Operating Expenses | 44,547 | 53,525 | 68,155 | 31,147 | 16,197 |
| Operating Income | -23,554 | -25,975 | -35,244 | -16,504 | -14,534 |
| Interest Expense | 5,937 | 2,837 | 2,573 | 2,123 | 539 |
| Other Income | -5,359 | -3,468 | 1,402 | 5,039 | -61 |
| Pre-tax Income | -34,849 | -32,280 | -36,415 | -13,587 | -15,133 |
| Net Income Continuous | -34,849 | -32,280 | -36,415 | -13,587 | -15,133 |
| Net Income | $-34,849 | $-32,280 | $-36,415 | $-13,587 | $-15,133 |
| EPS Basic Total Ops | -324.32 | -351.35 | -477.48 | -564.56 | -11,489.49 |
| EPS Basic Continuous Ops | -323.90 | -351.54 | -476.62 | -432.09 | -8,000.99 |
| EPS Diluted Total Ops | -324.32 | -351.35 | -477.48 | -564.56 | -11,489.49 |
| EPS Diluted Continuous Ops | -323.90 | -351.54 | -476.62 | -432.09 | -8,000.99 |
| EBITDA(a) | $-22,533 | $-25,102 | $-34,430 | $-15,848 | $-14,050 |